Malaysia Pharmaceuticals Research
22 comprehensive market analysis studies and research reports on the Malaysia Pharmaceuticals sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 4813 companies, enriched with industry statistics, insights, and a lot more.
TRENDING REPORTS
Over The Counter Drugs Market
CAGR: 4.80%
Study Period : 2019 - 2030
India Pharmaceutical Market
CAGR: 5.92%
Study Period : 2019 - 2030
Europe Over-the-Counter (OTC) Drugs Market
CAGR: 4.26%
Study Period : 2019 - 2030
Asia-Pacific Medical Clinical Nutrition Market
CAGR: 7.22%
Study Period : 2019 - 2030
Dermatological Therapeutics Market
CAGR: 9.67%
Study Period : 2019 - 2030
Healthcare
Categories
22 Healthcare Reports
Categories
Showing 22 of 22 results in Pharmaceuticals
Dipeptide Peptidase 4 Inhibitors Market
CAGR: 2.78%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Merck, AstraZeneca, Boehringer Ingelheim, Pfizer, Eli Lilly and Company
Basal Insulin Market
CAGR: 4.70%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Novo Nordisk, Sanofi, Eli Lilly and Company, Biocon, Wockhardt
Asia-Pacific Insulin Therapeutics Market
CAGR: 2.54%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Novo Nordisk, Eli Lilly and Company, Sanofi, Biocon, Gan & Lee
TRENDING REPORTS
Over The Counter Drugs Market
CAGR: 4.80%
Study Period : 2019 - 2030
India Pharmaceutical Market
CAGR: 5.92%
Study Period : 2019 - 2030
Europe Over-the-Counter (OTC) Drugs Market
CAGR: 4.26%
Study Period : 2019 - 2030
Asia-Pacific Medical Clinical Nutrition Market
CAGR: 7.22%
Study Period : 2019 - 2030
Dermatological Therapeutics Market
CAGR: 9.67%
Study Period : 2019 - 2030
Asia-Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
CAGR: 3.80%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:AstraZeneca, Eli Lilly and Company, Merck, Novartis, Bristol-Myers Squibb
Asia-Pacific Diabetes Drugs Market
CAGR: 2.81%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Eli Lilly and Company, Sanofi
Asia-Pacific Sodium-dependent Glucose Cotransporter 2 Market
CAGR: 8.35%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Eli Lilly and Company, Boehringer Ingelheim, Janssen, AstraZeneca, Bristol-Myers Squibb
Malaysia Diabetes Drugs Market
CAGR: 3.10%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Eli Lilly and Company, Boehringer Ingelheim, AstraZeneca, Sanofi, Novo Nordisk
Halal Pharmaceuticals Market
CAGR: 12.58%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Greenfield Nutritions, Vitabiotics, Canvita, Zaytun, Vitabiotics
Trulicity Market
CAGR: 10%
Study Period: 2021 - 2030
Country Covered: Malaysia
Major Players:Eli Lilly and Company
Liraglutide Market
CAGR: 3.16%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Novo Nordisk
Malaysia Oral Anti-Diabetic Drug Market
CAGR: 3.06%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:AstraZeneca, Astellas Pharma, Eli Lilly and Company, Sanofi, Johnson & Johnson
Asia-Pacific Alpha-Glucosidase Inhibitors Market
CAGR: 2.30%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Takeda Pharmaceuticals, Pfizer, Bayer, Sun Pharmaceuticals Industries, Glenmark Pharmaceuticals
APAC Meglitinide Market
CAGR: 1.7%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Novo Nordisk, Glenmark Pharmaceuticals, Novartis, KISSEI PHARMACEUTICAL, Biocon
APAC Biguanide Market
CAGR: 2%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Takeda Pharmaceuticals, Bristol-Myers Squibb, Glenmark Pharmaceuticals, Merck, Sanofi
Sulfonylureas Market
CAGR: 3.12%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Sanofi, Pfizer, Merck, Torrent Pharmaceuticals, Dr. Reddy’s Laboratories
Meglitinide Market
CAGR: 2.21%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Glenmark Pharmaceuticals, Novartis, KISSEI PHARMACEUTICAL, Biocon, Novo Nordisk
Combination Anti-Diabetes Drugs Market
CAGR: 10.87%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Boehringer Ingelheim, Sanofi, Merck, Eli Lilly and Company, Novo Nordisk
Alpha-glucosidase Inhibitors Market
CAGR: 2.17%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Sun Pharmaceuticals Industries, Bayer, Takeda Pharmaceuticals, Torrent Pharmaceuticals, Pfizer
Oral Anti-Diabetic Drugs Market
CAGR: 4.17%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:Eli Lilly and Company, Astellas Pharma, Sanofi, Janssen, AstraZeneca
Glucagon-like Peptide-1 (GLP-1) Agonists Market
CAGR: 1.12%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:AstraZeneca, Eli Lilly and Company, Sanofi, Novo Nordisk, Pfizer
Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists Market
CAGR: 5.38%
Study Period: 2019 - 2030
Country Covered: Malaysia
Major Players:AstraZeneca, Eli Lilly and Company, Novo Nordisk, Sanofi, Biocon
Yay! You have seen it all
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.
